November 16, 2026 at 11:16 AM UTC
Vir Biotechnology, Inc. reports material agreement in SEC 8-K
Vir Biotechnology, Inc. filed an 8-K covering a material definitive agreement and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 14, 2026 at 02:47 AM UTC
Open official source